245 related articles for article (PubMed ID: 18366990)
1. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
Nomiyama T; Bruemmer D
Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
[TBL] [Abstract][Full Text] [Related]
2. Biological role of liver X receptors.
Baranowski M
J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
4. Liver x receptors: potential novel targets in cardiovascular diseases.
Bruemmer D; Law RE
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
6. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors: Xcreting Xol to combat atherosclerosis.
Francis GA; Annicotte JS; Auwerx J
Trends Mol Med; 2002 Oct; 8(10):455-8. PubMed ID: 12383763
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of LXR.
Michael LF; Schkeryantz JM; Burris TP
Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors as potential targets for modulating reverse cholesterol transport.
Pelton PD; Patel M; Demarest KT
Curr Top Med Chem; 2005; 5(3):265-82. PubMed ID: 15857310
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors and atherosclerosis.
Lala DS
IDrugs; 2004 Jun; 7(6):563-9. PubMed ID: 15197661
[TBL] [Abstract][Full Text] [Related]
14. The liver X receptors.
Lala DS
Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in liver X receptor biology and chemistry.
Goodwin BJ; Zuercher WJ; Collins JL
Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?
Ory DS
Circ Res; 2004 Oct; 95(7):660-70. PubMed ID: 15459087
[TBL] [Abstract][Full Text] [Related]
18. LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
Kalaany NY; Mangelsdorf DJ
Annu Rev Physiol; 2006; 68():159-91. PubMed ID: 16460270
[TBL] [Abstract][Full Text] [Related]
19. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
Bradley MN; Hong C; Chen M; Joseph SB; Wilpitz DC; Wang X; Lusis AJ; Collins A; Hseuh WA; Collins JL; Tangirala RK; Tontonoz P
J Clin Invest; 2007 Aug; 117(8):2337-46. PubMed ID: 17657314
[TBL] [Abstract][Full Text] [Related]
20. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
